Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE)

Abstract

Background and study aims Besides increasing adequacy, rapid on-site evaluation (ROSE) during endoscopic ultrasound (EUS) or endoscopic retrograde cholangiopancreatography (ERCP) may impact choices and timing of subsequent therapeutic procedures, yet has been unexplored.

Patients and methods This was a retrospective evaluation of a prospectively maintained database of a tertiary, academic centre with availability of ROSE and hybrid EUS-ERCP suites. All consecutive patients referred for pathological confirmation of suspected malignancy and jaundice or gastric outlet obstruction (GOO) between Jan-2020 and Sep-2022 were included.

Results Of 541 patients with underlying malignancy, 323 (59.7%) required same-session pathological diagnosis (male: 54.8%; age 70 [interquartile range 63–78]; pancreatic cancer: 76.8%, biliary tract adenocarcinoma 16.1%). ROSE adequacy was 96.6%, higher for EUS versus ERCP. Among 302 patients with jaundice, ERCP-guided stenting was successful in 83.1%, but final drainage was completed in 97.4% thanks to 43 EUS-guided biliary drainage procedures. Twenty-one patients with GOO were treated with 15 EUS-gastroenterostomies and six duodenal stents. All 58 therapeutic EUS procedures occurred after adequate ROSE. With ERCP-guided placement of stents, the use of plastic stents was significantly higher among patients with inadequate ROSE (10/11; 90.9%) versus adequate sampling (14/240; 5.8%) P <0.0001; OR 161; 95%CI 19–1352). Median hospital stay for diagnosis and palliation was 3 days (range, 2–7) and median time to chemotherapy was 33 days (range, 24–47).

Conclusions Nearly two-thirds of oncological candidates for endoscopic palliation require contemporary pathological diagnosis. ROSE adequacy allows, since the index procedure, state-of-the-art therapeutics standardly restricted to pathologically confirmed malignancies (e.g. uncovered SEMS or therapeutic EUS), potentially reducing hospitalization and time to oncological treatments.

Keywords

Endoscopic ultrasonography - Pancreatobiliary (ERCP/PTCD) - Tissue diagnosis - Fine-needle aspiration/biopsy - Intervention EUS

Publikationsverlauf

Eingereicht: 28. August 2023

Angenommen nach Revision: 15. Januar 2024

Accepted Manuscript online:
22. Januar 2024

Artikel online veröffentlicht:
28. Februar 2024

• References

• 1 Gordon-Dseagu VL, Devesa SS, Goggins M. et al. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol 2018; 47: 427-439
• 2 Rahib L, Smith BD, Aizenberg R. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74: 2913-2921
• 3 Swords DS, Mone MC, Zhang C. et al. Initial misdiagnosis of proximal pancreatic adenocarcinoma is associated with delay in diagnosis and advanced references stage at presentation. J Gastrointest Surg 2015; 19: 1813-1821
• 4 Pitter JG, Lukács G, Csanádi M. et al. Clinical impact of treatment delay in pancreatic cancer patients revisited. Int J Cancer 2018; 142: 2621-2622
• 5 Sanjeevi S, Ivanics T, Lundell L. et al. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg 2016; 103: 267-275
• 6 Pouw RE, Barret M, Biermann K. et al. Endoscopic tissue sampling - Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; 53: 1174-1188
• 7 Vanella G, Bronswijk M, Arcidiacono PG. et al. Current landscape of therapeutic EUS: Changing paradigms in gastroenterology practice. Endosc Ultrasound 2023; 12: 16-28
• 8 Polkowski M, Jenssen C, Kaye P. et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline - March 2017. Endoscopy 2017; 49: 989-1006
• 9 Crinò SF, Di Mitri R, Nguyen NQ. et al. Endoscopic ultrasound-guided fine-needle biopsy with or without rapid on-site evaluation for diagnosis of solid pancreatic lesions: a randomized controlled non-inferiority trial. Gastroenterology 2021; 161: 899-909.e5
• 10 Fujii-Lau LL, Thosani NC, Al-Haddad M. et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: Summary and Recommendations. Gastrointest Endosc 2023; 98: 685-693
• 11 Archibugi L, Mariani A, Ciambriello B. et al. High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures. Endosc Int Open 2021; 9: E363-E370
• 12 Sawas T, Al Halabi S, Parsi MA. et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 2015; 82: 256-267.e7
• 13 Van Der Merwe SW, Van Wanrooij RLJ, Bronswijk M. et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54: 185-205
• 14 Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002; 97: 72-78
• 15 Vanella G, Coluccio C, Cucchetti A. et al. Fully versus partially-covered self-expandable metal stents for palliation of distal malignant biliary obstruction: a meta-analysis.. Gastrointest Endosc 2023;
• 16 Vanella G, Bronswijk M, Dell’Anna G. et al. Classification, risk factors, and management of lumen apposing metal stent dysfunction during follow-up of endoscopic ultrasound-guided choledochoduodenostomy: Multicenter evaluation from the Leuven-Amsterdam-Milan Study Group. Dig Endosc 2023; 35: 377-388
• 17 Vanella G, Bronswijk M, Maleux G. et al. EUS-guided intrahepatic biliary drainage: a large retrospective series and subgroup comparison between percutaneous drainage in hilar stenoses or postsurgical anatomy. Endosc Int Open 2020; 08: E1782-E1794
• 18 Vanella G, Dell’Anna G, Capurso G. et al. EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting. Gastrointest Endosc 2023; 98: 337-347.e5
• 19 Bronswijk M, Vanella G, Petrone MC. et al. EUS-guided gastroenterostomy: Less is more! The wireless EUS-guided gastroenterostomy simplified technique. VideoGIE 2020; 5: 442
• 20 Facciorusso A, Gkolfakis P, Tziatzios G. et al. Comparison between EUS-guided fine-needle biopsy with or without rapid on-site evaluation for tissue sampling of solid pancreatic lesions: A systematic review and meta-analysis. Endosc Ultrasound 2022; 11: 458
• 21 Diogo Turiani Hourneaux Moura A, Guidamarães Hourneaux de Moura E, Eiji Matuguma S. et al. EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures: a prospective comparative study. Endosc Int Open 2018; 06: E769-E777
• 22 Jenssen C, Alvarez-Sánchez MV, Napoléon B. et al. Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol 2012; 18: 4659-4676
• 23 Archibugi L, Ponz de Leon Pisani R, Petrone MC. et al. Needle-tract seeding of pancreatic cancer after EUS-FNA: a systematic review of case reports and discussion of management. Cancers (Basel) 2022; 14: 6130
• 24 Facciorusso A, Crinò SF, Gkolfakis P. et al. Needle tract seeding after endoscopic ultrasound tissue acquisition of pancreatic lesions: a systematic review and meta-analysis. Diagnostics (Basel) 2022; 12: 2113
• 25 Ngamruengphong S, Xu C, Woodward TA. et al. Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needle aspiration. Endoscopy 2013; 45: 619-626
• 26 Ngamruengphong S, Swanson KM, Shah ND. et al. Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer. Gut 2015; 64: 1105-1110
• 27 Kojima H, Kitago M, Iwasaki E. et al. Peritoneal dissemination of pancreatic cancer caused by endoscopic ultrasound-guided fine needle aspiration: A case report and literature review. World J Gastroenterol 2021; 27: 294-304
• 28 Heimbach JK, Sanchez W, Rosen CB. et al. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 2011; 13: 356-360
• 29 Iglesias-Garcia J, Lariño-Noia J, Abdulkader I. et al. Rapid on-site evaluation of endoscopic-ultrasound-guided fine-needle aspiration diagnosis of pancreatic masses. World J Gastroenterol 2014; 20: 9451-9457
• 30 Matynia AP, Schmidt RL, Barraza G. et al. Impact of rapid on-site evaluation on the adequacy of endoscopic-ultrasound guided fine-needle aspiration of solid pancreatic lesions: a systematic review and meta-analysis. J Gastroenterol Hepatol 2014; 29: 697-705
• 31 Chafic AH El, Dewitt J, LeBlanc JK. et al. Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients. Endoscopy 2013; 45: 883-889
• 32 Pedersoli F, Schröder A, Zimmermann M. et al. Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. nondilated bile ducts: technical considerations and complications. Eur Radiol 2020; 31: 3035-3041
• 33 Behera RK, Srivastava DN, Kumar P. et al. Right-sided versus left-sided percutaneous transhepatic biliary drainage in the management of malignant biliary obstruction: a randomized controlled study. Abdominal Radiology 2021; 46: 768-775
• 34 Dumonceau JM, Tringali A, Papanikolaou IS. et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy 2018; 50: 910-930